Cannabis

In recent decades, research into the properties of cannabis and its derivatives has opened broad horizons for medicinal, therapeutic and industrial use and has led to important regulatory and legislative changes in several countries.

Our firmbelieves that following and reviewing trends is critical to a successful venture. Thus, our cannabis practice area represents and advises multinationals, public and private companies, investment funds, financial institutions and entrepreneurs in various sectors, such as life sciences, pharmaceutical, technology and financial services, keeping them always abreast of innovations, strategies and risks of the sectors of interest.

Our expertise allows customers in the sector to know in detail the rules of pharmaceutical regulation, to carry out the activities in full compliance with national legislation. In addition, we ally our corporate experience with our strategic presence in Brasilia, Brazil’s capital city, to advise our clients in the dialogue between private companies and the public sector, towards the regulatory development of this market.

When clients develop activities in this market, we assist them since incorporation and funding of their business up to development of operations and exit strategies. Our multidisciplinary team is prepared to assist foreign investors into Brazil and support Brazilian companies in their international expansion, leveraging on our presence in Canada to add expertise and strategic contacts in the access to Canadian capital.

At last, our Compliance practice works both on preventive works and on remediation of damages, including by performing legal due diligence on counterparties, such as joint-ventures, investors, suppliers and clients.